Dr Sebastian Fuller
Senior Postdoctoral Social Scientist
Implementation Science in Global Health
Dr Sebastian Fuller is a Senior Postdoctoral Social Scientist in implementation science in global health. Following his MA in cultural anthropology he worked as a behavioural health researcher in the USA, and as a health extension volunteer in Ghana, before receiving his PhD from University College London.
Sebastian’s work has ranged from investigation of adoption of new point-of-care tests for STIs into the British healthcare system, understanding the social acceptability of gene editing for the development of novel healthcare and food products in Europe, and investigating social and structural barriers and facilitators to implementing diagnostic tests in low- and middle-income countries. He has received funding from the European Commission Horizon 2020 programme, the European and Developing Countries Clinical Trials Partnership (EDCTP), the UK National Institute of Health Research (NIHR), Innovate UK, and the US President's Plan for Emergency AIDS Relief (PEPFAR).
Sebastian’s research is focused on investigating the methods of translating novel technologies into practice and the implications of this on health systems and populations. His work on the NIHR- funded HIGH-Q project is focused on co-development of new technologies, and understanding how governance and ethical oversight of adoption of technologies impact access to healthcare. He is also an invited consultant for the World Health Organization Department of Sexual and Reproductive Health and Research, and leads social science and public/patient engagement work for the European Commission -funded Pharma-Factory and Photoboost projects.
High prevalence of coinfection of azithromycin-resistant Mycoplasma genitalium with other STIs: a prospective observational study of London-based symptomatic and STI-contact clinic attendees
Broad CE. et al, (2021), SEXUALLY TRANSMITTED INFECTIONS, 97, 63 - 68
Molecular Pharming for low and middle income countries.
Murad S. et al, (2020), Current opinion in biotechnology, 61, 53 - 59
New Hope for a "Cursed" Crop? Understanding Stakeholder Attitudes to Plant Molecular Farming With Modified Tobacco in Europe.
Menary J. et al, (2020), Frontiers in plant science, 11
Shotguns vs Lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products.
Menary J. et al, (2020), PloS one, 15
"It's not a time spent issue, it's a 'what have you spent your time doing?' issue. . ." A qualitative study of UK patient opinions and expectations for implementation of Point of Care Tests for sexually transmitted infections and antimicrobial resistance
Fuller SS. et al, (2019), PLOS ONE, 14